The pharmaceutical landscape is seeing a development with the arrival of GLP-1 delivery devices. These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 medication for individuals living with type 2 diabetes . Instead of needles, a simple patch applied to the body could provide a steady amount of the sub